ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Starnes, V. A.
Right arrow Articles by Shumway, N. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Starnes, V. A.
Right arrow Articles by Shumway, N. E.

The Annals of Thoracic Surgery, Vol 53, 306-310, Copyright © 1992 by The Society of Thoracic Surgeons


ARTICLES

Heart, heart-lung, and lung transplantation in the first year of life

VA Starnes, PE Oyer, D Bernstein, D Baum, P Gamberg, J Miller and NE Shumway
Department of Cardiothoracic Surgery, Stanford University Medical Center, California 94305.

Seventeen infants less than 1 year of age have undergone heart (12), heart-lung (3), and lung (2) transplantation for end-stage cardiopulmonary disease. The infants undergoing heart transplantation had a mean age of 4.5 months (range, 19 days to 12 months) with the diagnosis of cardiomyopathy in 4 and congenital heart disease in 8. Four of the 8 patients (50%) had hypoplastic left heart syndrome. Actuarial survival at 1 and 2 years was 74% and compared favorably with the survival of older children at 1 and 2 years of 82% and 69%. The linearized rejection rate was less in infants as compared with children more than 1 year of age (0.61 versus 1.48 episodes per 100 patient days). In intermediate follow-up, no graft atherosclerosis has been noted. Immunosuppression has included a three-drug protocol of cyclosporine, azathioprine, and prednisone. A steroid taper to alternate day steroids or off completely by 6 months has been the goal and has been accomplished in 6 of 12 infants. Heart-lung and lung transplantation has been performed in 5 infants. One infant in each group died: 1 infant secondary to airway complications and sepsis and another due to pulmonary sepsis. A pulmonary lobe from a larger and older donor was transplanted into a 4-week-old infant as a single-lung transplant with good outcome. The 3 surviving infants are well 24, 18, and 2 months after transplantation. Obliterative bronchiolitis has not been clinically apparent in this group. These data support the clinical efficacy of heart, heart-lung, and lung transplantation in the first year of life.


This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
Y. S. Tjang, U. Blanz, L. Hornik, G. Tenderich, M. Morshuis, H. Stenlund, A. Bairaktaris, and R. Korfer
Heart Transplantation in Children: Clinical Outcomes in a Single Center
Ann. Thorac. Surg., November 1, 2007; 84(5): 1640 - 1644.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
C. K. Choong, S. C. Sweet, T. J. Guthrie, E. N. Mendeloff, F. J. Haddad, P. Schuler, M. D. L. Morena, and C. B. Huddleston
Repair of congenital heart lesions combined with lung transplantation for the treatment of severe pulmonary hypertension: A 13-year experience
J. Thorac. Cardiovasc. Surg., March 1, 2005; 129(3): 661 - 669.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
M. Murtra
The adventure of cardiac surgery
Eur. J. Cardiothorac. Surg., February 1, 2002; 21(2): 167 - 180.
[Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
R. L. Applegate, L. J. Mason, and T. L. Thompson
Anesthetic Management of Pediatric Cardiac Transplantation
Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2001; 5(1): 55 - 61.
[Abstract] [PDF]


Home page
NeoReviewsHome page
D. Bernstein
Heart Transplantation in Neonates: Achievements, Controversies, and Challenges for the Future
NeoReviews, August 1, 2000; 1(8): e152 - 159.
[Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
V. A. Starnes, M. L. Barr, R. G. Cohen, J. A. Hagen, W. J. Wells, M. V. Horn, and F. A. Schenkel
LIVING-DONOR LOBAR LUNG TRANSPLANTATION EXPERIENCE: INTERMEDIATE RESULTS
J. Thorac. Cardiovasc. Surg., November 1, 1996; 112(5): 1284 - 1291.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
V. Alexi-Meskishvili, R. Hetzer, Y. Weng, P. E. Lange, Z. Jin, F. Berger, and M. Loebe
Anomalous origin of the left coronary artery from the pulmonary artery: Early results with direct aortic reimplantation
J. Thorac. Cardiovasc. Surg., August 1, 1994; 108(2): 354 - 362.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1992 by The Society of Thoracic Surgeons.